a year ago
HIMS
AnalystsJack WallaceJack Wallace's Stock Forecasts
AnalystsJack Wallace
Analyst Ranking
Bottom 17%
#3806 out of 4554 analysts
Average Return
-1.88%
Win Rate
45%9 out of 20
Risk vs Reward
Poor
Good
Jack Wallace's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Hims & Hers Health IncHIMS | +98.62% | $5.06 | $10.05 | 2022-04-13 - 2023-04-13 | Strong Buy |
Phreesia IncPHR | +60.68% | $20.32 | $32.65 | 2022-06-02 - 2023-06-02 | Strong Buy |
Nextgen Healthcare IncNXGN | +52.87% | $15.66 | $23.94 | 2023-05-22 - 2023-11-08 | Strong Buy |
Nextgen Healthcare IncNXGN | +48.14% | $16.16 | $23.94 | 2023-07-24 - 2023-11-08 | Strong Buy |
Hims & Hers Health IncHIMS | +18.28% | $11.27 | $13.33 | 2023-02-27 - 2024-02-28 | Strong Buy |
Jack Wallace Analyst Color
Get additional color on Jack Wallace's coverage of popular stocks
a year ago
PHR
Jack Wallace's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
R1 Rcm IncRCM | 4 | Strong Buy | $15.00 | +24.79% | Maintains | 15 days ago |
Ww International IncWW | 2 | Strong Buy | $12.00 | +559.34% | Reiterates | a month ago |
Hims & Hers Health IncHIMS | 4 | Strong Buy | $17.00 | +37.76% | Maintains | 2 months ago |
Health Catalyst IncHCAT | 2 | Strong Buy | $14.00 | +145.83% | Upgrades | 3 months ago |
Iqvia Holdings IncIQV | 1 | Strong Buy | $220.00 | -3.16% | Maintains | 6 months ago |
Nextgen Healthcare IncNXGN | 3 | Strong Buy | $22.00 | -8.10% | Reiterates | 9 months ago |
Veeva Systems IncVEEV | 1 | Strong Buy | $226.00 | +13.26% | Upgrades | a year ago |
Phreesia IncPHR | 3 | Strong Buy | $40.00 | N/A | Maintains | a year ago |
American Well CorpAMWL | 1 | Strong Buy | $5.00 | N/A | Reiterates | a year ago |
Premier IncPINC | 1 | Hold | N/A | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.